University of Salzburg   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Salzburg Austria (1622)

Organization Overview

First Clinical Trial
2004
NCT00565981
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Department of Anesthesiology, University Hospital Salzburg | Department of Obstetrics and Gynecology, University Hospital Salzburg, Austria | IIIrd Medical Department for Hematology, Oncology, Rheumatology, Infectiology and Hemostasiology at the Medical University of Salzburg | Medical University of Salzburg | Medical University of Salzburg, Department of Neurology, Austria | PMU Salzburg | Prof. Johann Bauer | Salzburger Landeskliniken | Universitaetsklinik f. Innere Medizin III, Universitaetsklinikum der PMU, Salzburg | Universitaetsklinikum der PMU, Salzburg | University of Salzburg

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Altitude Sickness (Phase 1)

Bile Duct Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Ductal (Phase 2)

Carcinoma in Situ (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 3)

Epidermolysis Bullosa (Phase 2)

Epidermolysis Bullosa Dystrophica (Phase 2)

Epilepsies, Partial (Phase 4)

Epilepsy (Phase 4)

HIV Infections (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Neoplasms (Phase 3)

Skin Neoplasms (Phase 2)

Urinary Incontinence, Stress (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 21